Results of this study could change the practice of how brain metastases are managed in the United States, says M.D. Anderson researcher at ASTRO.
Varian Medical Systems Commissions Additional Treatment Gantry at Rinecker Proton Therapy Center.
Self-collimating system could reduce radiation exposure while providing superior image quality
MTMI provides the first CME conference dedicated to Intensity Modulated Arc Therapy.
Cuts radiation exposure from the exam in half
Leading associations team on important effort.
ASTRO board member appointed to CMS Advisory Panel on Hospital Outpatient Payment
The future is hypofractionated: Insights from Dr. Robert D. Timmerman
New catheter for heart can be guided without live X-ray.
Installs MAGNETOM Terra.X scanner at Auburn University
Estimates brain region volumes and improves lesion analysis
An important option in cancer treatment comes to Oklahoma City.
Radiation therapy deal announced earlier this year comes to America.
Smaller and less expensive systems
Treat all stages of cancer, including metastatic
Copenhagen University Hospital, Herlev investigator to start research projects on role of patient-friendly 3D ultrasound in image guided radiation therapy
Preliminary analysis has shown a decrease in number of portable chest x-rays and chest CTs for ICU patients
Xenotransplants could potentially reduce organ shortages
Market predicted to be more than $8 billion by 2027
New Illinois proton therapy center on track to treat patients with cancer in 2011.
Will develop new clinical trials, expand specialty care access for patients.
The first dedicated breast coil was introduced more than 30 years ago. Since that time, breast MR has proven its value as a breast imaging modality.
Mice given high enough doses of radiation to cause leukemia remained cancer free after receiving one of two types of bisphosphonates, drugs that build bone mineral density in people with osteoporosis.
Photon-counting CT decreases pixel size, improves spatial resolution
Higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.